tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Actuate Therapeutics, Inc. (ACTU) Similar Stocks

Compare
10 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$9.16
2 Buy
0 Hold
0 Sell
Moderate Buy
Biodexa Pharmaceuticals
$1.46
$976.14K
-95.54%
0 Buy
0 Hold
0 Sell
Moderate Buy
Applied DNA Sciences
$0.88
$5.74M
-99.56%
0 Buy
1 Hold
0 Sell
Hold
Salarius Pharmaceuticals
$0.71
$1.51M
-82.21%
Hepion Pharmaceuticals
$0.29
$3.18M
-99.58%
ZyVersa Therapeutics
$0.61
$2.44M
-88.49%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
9.20
0.05
0.55%
BDRX
Biodexa Pharmaceuticals
1.46
-29.54
-95.29%
APDN
Applied DNA Sciences
0.88
-203.62
-99.57%
SLRX
Salarius Pharmaceuticals
0.71
-3.51
-83.18%
HEPA
Hepion Pharmaceuticals
0.29
-75.71
-99.62%
ZVSA
ZyVersa Therapeutics
0.61
-5.13
-89.37%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis